AHCO | Ticker Profile - Titan Protect

AHCO

AdaptHealth Corp.

Healthcare · Medical Devices · NCM

$9.89

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

HIGH

Data Confidence: 85.7%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$1.4B

Total market value of the company

Trailing P/E

N/A

Forward P/E

8.82

Based on estimated future earnings — lower means cheaper

Rev Growth

+5.4%

Year-over-year revenue change

Profit Margin

-2.4%

How much profit the company keeps from each dollar of revenue

ROE

-4.8%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$14.00

+42% from current price — median analyst estimate

Recommendation

BUY

Consensus view from 8 analysts covering this stock

About AdaptHealth Corp.

AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services; and medical devices, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; and other HME devices and supplies. It also provides PAP machines, wheelchairs, hospital beds, oxygen concentrators, ventilators, insulin pumps, diabetes management and wound care supplies, orthopedic bracing, breast pumps and supplies, walkers, commodes, enteral supplies, and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Conshohocken, Pennsylvania.

https://adapthealth.com

Country: United States Employees: 10,900 Industry: Medical Devices

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKDOWN

Price trending down — defensive positioning

Sharpe Ratio

0.297

Positive but modest risk-adjusted returns

Kelly Fraction

0.0079

Marginal edge — very small allocation suggested

Calmar Ratio

0.049

Drawdown risk outweighs the returns — higher risk profile

Annual Return

1.8%

Historical annualised return based on price data

Max Drawdown

-36.8%

Largest peak-to-trough decline — the worst it has been

HMM State

CRISIS

Elevated risk detected — extreme caution warranted

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

1.57

Significantly more volatile than the market

52W High

$13.43

26% below the year high

52W Low

$8.06

23% above the year low

Avg Volume

1,477,513

Average daily shares traded — higher means easier to buy and sell

Short Ratio

4.6

Days it would take all short sellers to cover — higher means more crowded

Short % Float

7.0%

Moderate short interest

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$-0.59

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

132.11

Heavy leverage — higher financial risk if revenues decline

Current Ratio

0.93

Below 1 means short-term obligations exceed liquid assets — risk flag

Quick Ratio

0.61

Like current ratio but excludes inventory — stricter test

Gross Margin

20.4%

Revenue left after cost of goods — higher means pricing power

Operating Margin

0.7%

Profit from core operations before interest and tax

Free Cash Flow

$268M

Positive — the business generates more cash than it spends

Revenue (TTM)

$3.3B

Total revenue over the last 12 months

Net Income

$-79,627,000

Loss-making — spending exceeds revenue after all costs

Analyst Coverage

Analysts

Target High

$18.00

Target Median

$14.00

Target Low

$11.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go